|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-2-11
|
|
pubmed:abstractText |
Membranous and cytoplasmic Ki67 immunoreactivity has recently been observed in a number of histopathological entities, but frequency of occurrence and relationship to prognosis in more common cancers have not been described. The aim was to describe the pattern and frequency of membranous/cytoplasmic Ki67 in a cohort of invasive breast carcinomas, and their associations with grade, HER2 amplification and oestrogen receptor (ER) expression.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1365-2559
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
254-7
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:19207951-Breast Neoplasms,
pubmed-meshheading:19207951-Carcinoma, Ductal, Breast,
pubmed-meshheading:19207951-Cell Membrane,
pubmed-meshheading:19207951-Cytoplasm,
pubmed-meshheading:19207951-Female,
pubmed-meshheading:19207951-Gene Amplification,
pubmed-meshheading:19207951-Humans,
pubmed-meshheading:19207951-Immunohistochemistry,
pubmed-meshheading:19207951-In Situ Hybridization, Fluorescence,
pubmed-meshheading:19207951-Ki-67 Antigen,
pubmed-meshheading:19207951-Prognosis,
pubmed-meshheading:19207951-Receptor, erbB-2,
pubmed-meshheading:19207951-Receptors, Estrogen,
pubmed-meshheading:19207951-Tumor Markers, Biological
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
|
|
pubmed:affiliation |
Division of Pathology and Endocrine Cancer Group, University of Edinburgh Cancer Research Centre, Edinburgh, UK.
|
|
pubmed:publicationType |
Journal Article
|
